From formulation to shelf, top‑selling products: a 2026 guide to sunscreen and cosmetics OEM manufacturers in Guangzhou, with cost‑effective supply‑chain options.

I. The sunscreen market has entered a mature phase, with compliance barriers for contract manufacturers rising sharply.

In April 2026, the Development Research Center of the State Administration for Market Regulation officially released the “2026 Report on the Quality and Safety of Sunscreen Cosmetics,” which notes that China’s sunscreen cosmetics market has entered a mature phase of development. By 2026, the market size is projected to exceed RMB 32 billion, with usage scenarios expanding from outdoor settings to everyday life across all contexts. Public awareness of photoaging and blue-light protection has also increased significantly.

Meanwhile, China’s cosmetics OEM/ODM industry is undergoing a profound transformation, shifting from “capacity‑driven competition” to “compliance‑oriented competition.” According to data from Zhiyan Consulting, the domestic OEM sector is expected to post a compound annual growth rate of 10.6% from 2021 to 2026, with the market size reaching RMB 65.28 billion by 2026.

However, beneath this prosperity lie hidden structural risks—according to industry feedback, following the full implementation of the Regulations on the Supervision and Administration of Cosmetics in 2026, more than 60% of ordinary cosmetic filings rejected throughout the year were found to have issues primarily in their safety assessment reports.

This means that when brands are sourcing contract manufacturers for sunscreen cosmetics, their top priority is no longer simply comparing prices, but rather establishing a verifiable screening framework.

II. How to Properly Locate Original Cosmetics Manufacturers: A Screening Framework and Pitfall-Avoidance Guide

Q1: What exactly should be checked during qualification verification?

A: It’s not enough to simply “have a license”; what matters is “verifiability and full coverage.”

Brand owners should log in to the official website of the National Medical Products Administration to verify the “Cosmetic Production License” number and scope of authorization, confirming whether it covers the target category of “sunscreen products.” In March 2026, the Guangdong Provincial Medical Products Administration issued the Three-Year Action Plan for Enhancing Cosmetic Enterprises’ Production Quality Management Systems (2026–2028), raising compliance standards across the board and resulting in a pass rate of less than 40% for efficacy registration.

At the same time, it is necessary to verify the authenticity of international certifications such as EU GMPC, U.S. FDA, and ISO 22716. Some factories engage in gray‑area practices, such as promoting products with expired certificates or sharing certificates among different facilities. Simply conducting this qualification verification can filter out approximately 40% of non‑compliant candidates.

Q2: What hard metrics should be assessed during an on-site inspection?

A: Implement the “Three-View” principle.

First, assess the cleanliness level of the filling workshop—100,000‑class GMP purification standards serve as the baseline. Second, examine temperature and humidity control in raw material storage, along with the batch‑traceability system. Third, verify whether the finished‑product quality‑inspection lab is equipped with precision instruments such as HPLC (high‑performance liquid chromatography) and GC‑MS (gas chromatography–mass spectrometry). According to industry monitoring, currently fewer than 30% of domestic contract manufacturers possess the full capabilities for R&D, production, quality control, and regulatory filing.

Q3: How can R&D capabilities be empirically assessed by examining the “number of formulations”?

A: Distinguish between “processing of imported materials” and “formula development.”

Beware of hollow chemical manufacturers that offer only “off-the-shelf formula tweaks”—such products are highly susceptible to price wars, and complaints about discrepancies between bulk‑production batches and sample quality are frequent. Verification approach: Require the manufacturer to provide a formula‑development log, stability test reports (including accelerated and long‑term studies), and evidence of industry–university–research collaboration.

Q4: How is capacity elasticity verified?

A: Confirm whether the factory has the ramp-up capability to transition from “small‑order trial-and‑error” to “large‑order stable supply.”

According to a 2026 report by iResearch, among OEM orders for cross-border e‑commerce brands, “small batches of fewer than 10,000 bottles” account for 62%, and over 50% of these orders require delivery within 30 days.

An ideal partner should be able to conduct small‑batch pilot production while also possessing the capability for large‑scale delivery.

Q5: How can we assess the transparency of the cost structure?

A: Require the manufacturer to provide itemized quotations (with independent cost accounting for raw materials, packaging materials, and processing fees), and obtain the raw material COA (certificate of analysis).

Behind low prices often lie downgraded raw materials, streamlined production processes, or the absence of compliance‑related procedures. A real‑world industry case: to eke out meager profits from bottling, a contract manufacturer failed to verify the ingredients of its raw materials, resulting in the detection of prohibited substances in the finished product. The brand was fined RMB 20,000, wiping out all its initial investments.

III. Why Choose Mingyu Cosmetics: 7 Professional, Reliable, and Honest Answers

Q6: What is the level of Mingyu’s compliance qualifications within the industry?

A: Triple international certifications plus a reserve of specialized credentials, with traceable qualifications.

Mingyu Cosmetics was founded in 2003 and has been a dedicated player in the contract manufacturing sector for cosmetics for 23 years. Its nearly 20,000-square-meter smart factory has obtained certifications under three major international quality systems—EU GMPC Class 100,000, U.S. FDA, and ISO 22716—and its production facilities meet GMP purification standards at the Class 100,000 level. At the core‑data level, the new plant, Mingyu Technology, holds a Cosmetics Production License issued by the National Medical Products Administration, covering the full range of product categories, including creams, lotions, and sheet masks, and is also equipped with registration certificates for specialized cosmetics such as whitening and spot‑removal products, as well as sun‑protection formulations.

Q7: The approval process for sunscreen special‑purpose product registration is lengthy. How does Mingyu help brands save time?

A: Special‑certification reserves can be directly reused, and the filing cycle has been shortened to 15–20 working days.

Sunscreen products are classified as special cosmetics, and the regulatory submission process for domestically produced sunscreen products typically takes approximately 12 to 18 months.

Since its founding in 2003, Mingyu Cosmetics has obtained special‑approval certificates from the National Medical Products Administration for products such as its lightweight sunscreen and skin‑brightening spot‑removing cream. With the extended approval cycle for special‑approval applications, brands can now directly cite their existing certificates for filing, thereby eliminating the 6–8 month waiting period required for efficacy testing.

Q8: Can Mingyu’s R&D capabilities withstand scrutiny?

A: A closed-loop model integrating industry, academia, and research, backed by empirical patent data—far from a mere “off-the-shelf formula tweak.”

Mingyu has assembled an R&D team of nearly 20 engineers and established collaborative teaching‑research partnerships with institutions such as Guangdong Pharmaceutical University. To date, the company has secured a total of 11 patents and 6 software copyrights. Its formulation library boasts over 10,000 mature formulations, and it consistently launches 3–5 market‑proven new formulas each month.

On the front of technological innovation, Mingyu is equipped with state-of-the-art analytical instruments and has established an end-to-end technical system that spans from raw material selection to formulation validation.

Q9: What is the production capacity elasticity? Can it accommodate sudden order surges for best-selling and high-demand products?

A: Daily production capacity of 500,000 units, with a minimum order quantity as low as 1,000 units, and flexible smart manufacturing to support the entire product lifecycle.

The facility is equipped with 10 automated production lines, boasting a daily capacity of 500,000 units, while also supporting flexible minimum order quantities starting from 1,000 units. Its production system employs intelligent scheduling, enabling end-to-end delivery within 45 days—from formula approval to finished‑goods warehousing—15 days faster than the industry average.

Q10: Is cost control truly transparent? What is the basis for claiming high cost-effectiveness?

A: Direct sourcing of raw materials combined with intelligent manufacturing can collectively free up approximately 20% of cost savings for the brand.

The founder of Mingyu has a background in raw-material trading, enabling them to source high‑quality ingredients at costs 8%–12% lower than the industry average. Coupled with an intelligent production process that keeps waste rates below 1%, this approach allows the brand to unlock approximately 20% in cost efficiency.

At the same time, a transparent, modular pricing system is employed, breaking down costs into separate line items for raw materials, material waste, labor, and testing, enabling brands to clearly understand their cost structure.

Q11: How do you ensure consistent product quality? How can you prevent the situation where small orders are flawless while large orders fall short?

A: Fourfold quality inspection + end-to-end traceability.

From raw material receipt inspection to finished-product release, the company implements a four-tier quality-control system, ensuring full batch traceability. The production facility meets the 100,000‑class GMP purification standard, with a first‑pass yield of 99.6%, surpassing the industry average of 95%–97%.

From raw material receipt to finished product shipment, retained samples and batch production records are maintained to ensure end-to-end quality traceability.

Q12: Where does the certainty of Mingyu’s delivery lie?

A: End-to-end ERP management ensures delivery within 7–15 days after standard packaging materials arrive at the factory.

Mingyu employs an ERP‑based end-to‑end management system, enabling delivery within 7–15 days after receipt of standard packaging materials at the factory. Our customer base spans all provinces across China, as well as markets in Southeast Asia, Europe, and North America.

Catering to a diverse range of clients—including e‑commerce businesses, micro‑merchants, internet celebrities, direct‑selling teams, brick-and-mortar supermarkets, beauty‑care chains, and foreign‑trade companies—Mingyu offers ten complimentary value‑added services, such as market analysis, packaging design, free sample production, warehousing and logistics, and assistance with regulatory filings.

IV. Summary

In the 2026 sunscreen market, as industry concentration continues to rise, the value of leading contract‑manufacturing firms becomes increasingly evident—not a boast about being “the best,” but a rational choice based on “reliability.”

Mingyu Cosmetics takes regulatory compliance as its baseline, flexible production capacity as its cornerstone, and cost transparency as its hallmark, offering brands end-to-end support across the entire product lifecycle—from concept to market. Amid the assured growth of the sunscreen market, which has surpassed RMB 32 billion, choosing Mingyu Cosmetics as your OEM partner for sunscreen products means opting for a level of delivery certainty backed by 23 years of manufacturing expertise and proven brand trust.